Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Corrigendum to 'Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes' [JTO Clinical and Research Reports 6 (2025) 100914].
Journal: JTO clinical and research reports
Published: May 21, 2026
Corrigendum to "KRAS G12C inhibitor outcomes in advanced non-small cell lung cancer by smoking history, performance status, and KEAP1 mutation status" [Cancer Treatment and Research Communications 47 (2026) 101227].
Journal: Cancer treatment and research communications
Published: May 16, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.
Journal: NPJ precision oncology
Published: November 28, 2025
KRAS G12C inhibitor outcomes in advanced non-small cell lung cancer by smoking history, performance status, and KEAP1 mutation status.
Journal: Cancer treatment and research communications
Published: October 07, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy.
Journal: JTO clinical and research reports
Published: July 28, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 08, 2025
Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes.
Journal: JTO clinical and research reports
Published: May 02, 2025
QIM25-226: What Patients Anticipate About Working Out with Cancer: Qualitative Survey Results.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response.
Journal: JTO clinical and research reports
Published: February 19, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer.
Journal: Cancer discovery
Published: December 03, 2024
Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy.
Journal: JACC. CardioOncology
Published: August 15, 2024
Last Updated: 09/26/2026